Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Capital Expenditure | $0.0 | $0.0 | ($5,020.0K) | $0.0 | $0.0 | $0.0 | $6,733.0K | ($979.0K) | ($290.0K) | ($826.0K) | ($5,351.0K) | ($3,454.0K) | ($4,200.0K) | ($3,001.0K) | ($14.8M) | ($42.3M) | ($6,822.0K) | ($7,289.0K) | ($9,878.0K) | ($13.3M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Insmed Incorporated's last 12-month Capital Expenditure is ($21.9M), based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Insmed Incorporated's Capital Expenditure growth was 65.0%. The average annual Capital Expenditure growth rates for Insmed Incorporated have been 46.8% over the past three years, (12.3%) over the past five years.
Over the last year, Insmed Incorporated's Capital Expenditure growth was 65.0%, which is higher than industry growth of (0.6%). It indicates that Insmed Incorporated's Capital Expenditure growth is Bad.